All News

According to the FDA, patients should be selected based on an FDA-approved companion diagnostic test.

Remdesivir, the investigational drug for the treatment of the coronavirus disease 2019 (COVID-19), will be sold for $390 per vial.

Some states are implementing laws that are allowing pharmacists to expand their roles temporarily, but these laws vary by state and there is no uniformity in what all pharmacists can do during this time.

COVID-19 attacks the cardiovascular system and may exasperate preexisting heart conditions.

How could a patient be having a heart attack if the troponin levels were super low?

The dipeptide used in the study is the only known amino acid to make the trip from a mouse’s stomach to its brain intact, according to the study authors.

Current research has already found that CVD is among the most common pre-existing conditions among people who die from COVID-19.

A new study found disturbing evidence that black cancer survivors are more likely to face financial hardship on high deductible health plans than their white counterparts.

Organ transplants from seropositive donors carry a high risk of infection from the transplanted organ.

The paper is an update to previous guidelines released by ACSM and the American Heart Association in 1998.

Studying blood samples from critically ill patients at the London Health Sciences Center (LHSC), the researchers identified a unique pattern of 6 molecules that could be used as therapeutic targets to treat the virus, as reported in the Critical Care Explorations journal.

Dravet syndrome is a life-threatening, rare, and chronic form of epilepsy and is often characterized by severe, unrelenting seizures despite medical treatment, according to the FDA press release.

The measles, mumps, and rubella vaccine may hold the key to the mystery surrounding children and the COVID-19 pandemic.

The pharmaceutical industry is already seeing the immense benefit of AI and machine-learning technology.

Top news of the week from Pharmacy Times®.

What is the resource Approved Drug Products With Therapeutic Equivalence Evaluations commonly called?

Data from a new analysis reinforces concerns surrounding the detrimental impact the novel osteoporotic therapy romosozumab can have on cardiovascular health.

Many companies are working with health systems to transition patients from the hospital to in-home care as quickly as possible.

Pembrolizumab has been approved by the FDA as a monotherapy for the treatment of patients with recurrent or metastatic cutaneous squamous cell carcinoma.

According to the survey results, not only do a majority of the 500 respondents experience fear of bleeding events, but many of them also avoid or modify activities in order to mitigate their risk.

According to the investigators, payers and employers are increasingly adopting HDHPs in an effort to control rising health care costs.

Although researchers know that HIV enters the brain within 8 days of infection, less is known about whether HIV-infected brain cells can release the virus, letting it migrate from the brain back into the body to infect other tissues.

A recent qualitative study presented a potential explanation for why health system specialty pharmacies often find it difficult to partner with payers.

The trend toward elevating the role of the pharmacy technician makes this an exciting time to join the profession.

Cognitive impairment is extremely common among patients with MS, affecting approximately two-thirds of this patient population.

Pharmacists, being the most accessible health care professionals, have an important role to play in the management of this pandemic.

Orphan Drug Designation given to potential primary mitochondiral myopathies treatment.

The pharmacy department is generally responsible for making prepared syringes to be distributed prior to procedures.